{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:47:56Z","timestamp":1793368076003,"version":"4.5.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100007642","name":"Universit\u00e0 degli Studi di Roma Tor Vergata","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007642","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40265-026-02294-1","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:58:48Z","timestamp":1771505928000},"page":"443-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mucus as a Treatable Trait in Chronic Airway Diseases"],"prefix":"10.1007","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9707","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-5040","authenticated-orcid":false,"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-7851","authenticated-orcid":false,"given":"Josuel","family":"Ora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-069X","authenticated-orcid":false,"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-9235","authenticated-orcid":false,"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2294_CR1","unstructured":"Global initiative for asthma. Global strategy for asthma management and prevention 2025 report. https:\/\/ginasthma.org\/2025-gina-strategy-report\/. Accessed 28 Dec 2025."},{"key":"2294_CR2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2026 report. https:\/\/goldcopd.org\/2026-gold-report-and-pocket-guide\/. Accessed 28 Dec 2025."},{"issue":"6","key":"2294_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.chest.2023.06.040","volume":"164","author":"JM Roberts","year":"2023","unstructured":"Roberts JM, Goyal V, Kularatna S, et al. The economic burden of bronchiectasis: a systematic review. Chest. 2023;164(6):1396\u2013421. https:\/\/doi.org\/10.1016\/j.chest.2023.06.040.","journal-title":"Chest"},{"issue":"21","key":"2294_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/jama.2023.8120","volume":"329","author":"T Ong","year":"2023","unstructured":"Ong T, Ramsey BW. Cystic fibrosis: a review. JAMA. 2023;329(21):1859\u201371. https:\/\/doi.org\/10.1001\/jama.2023.8120.","journal-title":"JAMA"},{"issue":"2","key":"2294_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1183\/13993003.01359-2015","volume":"47","author":"A Agusti","year":"2016","unstructured":"Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410\u20139. https:\/\/doi.org\/10.1183\/13993003.01359-2015.","journal-title":"Eur Respir J"},{"issue":"5","key":"2294_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02058-2018","volume":"53","author":"VM McDonald","year":"2019","unstructured":"McDonald VM, Fingleton J, Agusti A, et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. Eur Respir J. 2019;53(5):1802058. https:\/\/doi.org\/10.1183\/13993003.02058-2018.","journal-title":"Eur Respir J"},{"issue":"10","key":"2294_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1701632","volume":"377","author":"M Kesimer","year":"2017","unstructured":"Kesimer M, Ford AA, Ceppe A, et al. Airway mucin concentration as a marker of chronic bronchitis. N Engl J Med. 2017;377(10):911\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1701632.","journal-title":"N Engl J Med"},{"issue":"3","key":"2294_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1172\/JCI95693","volume":"128","author":"EM Dunican","year":"2018","unstructured":"Dunican EM, Elicker BM, Gierada DS, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Investig. 2018;128(3):997\u20131009. https:\/\/doi.org\/10.1172\/JCI95693.","journal-title":"J Clin Investig"},{"issue":"20","key":"2294_CR9","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMra1813799","volume":"380","author":"RC Boucher","year":"2019","unstructured":"Boucher RC. Muco-obstructive lung diseases. N Engl J Med. 2019;380(20):1941\u201353. https:\/\/doi.org\/10.1056\/NEJMra1813799.","journal-title":"N Engl J Med"},{"issue":"21","key":"2294_CR10","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2023.2065","volume":"329","author":"AA Diaz","year":"2023","unstructured":"Diaz AA, Orejas JL, Grumley S, et al. Airway-occluding mucus plugs and mortality in patients with chronic obstructive pulmonary disease. JAMA. 2023;329(21):1832\u20139. https:\/\/doi.org\/10.1001\/jama.2023.2065.","journal-title":"JAMA"},{"issue":"9","key":"2294_CR11","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","volume":"205","author":"M Tang","year":"2022","unstructured":"Tang M, Elicker BM, Henry T, et al. Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time. Am J Respir Crit Care Med. 2022;205(9):1036\u201345. https:\/\/doi.org\/10.1164\/rccm.202110-2265OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2294_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.11.028","author":"S Ueki","year":"2025","unstructured":"Ueki S, Dunican E, Diaz AA. Mucus plugs and eosinophilic inflammation: Expanding the paradigm to COPD. J Allergy Clin Immunol Pract. 2025. https:\/\/doi.org\/10.1016\/j.jaip.2025.11.028.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"23","key":"2294_CR13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233\u201347. https:\/\/doi.org\/10.1056\/NEJMra0910061.","journal-title":"N Engl J Med"},{"issue":"6","key":"2294_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1164\/rccm.201804-0734OC","volume":"199","author":"K Okuda","year":"2019","unstructured":"Okuda K, Chen G, Subramani DB, et al. Localization of secretory mucins MUC5AC and MUC5B in normal\/healthy human airways. Am J Respir Crit Care Med. 2019;199(6):715\u201327. https:\/\/doi.org\/10.1164\/rccm.201804-0734OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2294_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chest.2017.11.008","volume":"154","author":"J Ma","year":"2018","unstructured":"Ma J, Rubin BK, Voynow JA. Mucins, mucus, and goblet cells. Chest. 2018;154(1):169\u201376. https:\/\/doi.org\/10.1016\/j.chest.2017.11.008.","journal-title":"Chest"},{"key":"2294_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.toxlet.2025.06.010","volume":"410","author":"A Mori","year":"2025","unstructured":"Mori A, Matsumoto R, Ichikawa S, Ishimori K, Ito S. Enhancement of cigarette smoke extract-induced goblet cell metaplasia and hyperplasia exerted through IL-13 receptor \u03b11 expression. Toxicol Lett. 2025;410:177\u201387. https:\/\/doi.org\/10.1016\/j.toxlet.2025.06.010.","journal-title":"Toxicol Lett"},{"issue":"2","key":"2294_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1513\/AnnalsATS.201711-868MG","volume":"15","author":"MA Seibold","year":"2018","unstructured":"Seibold MA. Interleukin-13 stimulation reveals the cellular and functional plasticity of the airway epithelium. Ann Am Thorac Soc. 2018;15(2):98\u2013102. https:\/\/doi.org\/10.1513\/AnnalsATS.201711-868MG.","journal-title":"Ann Am Thorac Soc"},{"issue":"19","key":"2294_CR18","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1074\/jbc.M210429200","volume":"278","author":"Y Chen","year":"2003","unstructured":"Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine\/autocrine loop. J Biol Chem. 2003;278(19):17036\u201343. https:\/\/doi.org\/10.1074\/jbc.M210429200.","journal-title":"J Biol Chem"},{"issue":"6","key":"2294_CR19","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1073\/pnas.96.6.3081","volume":"96","author":"K Takeyama","year":"1999","unstructured":"Takeyama K, Dabbagh K, Lee HM, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA. 1999;96(6):3081\u20136. https:\/\/doi.org\/10.1073\/pnas.96.6.3081.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2294_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6120112","volume":"6","author":"LR Bonser","year":"2017","unstructured":"Bonser LR, Erle DJ. Airway mucus and asthma: the role of MUC5AC and MUC5B. J Clin Med. 2017;6(12):112. https:\/\/doi.org\/10.3390\/jcm6120112.","journal-title":"J Clin Med"},{"issue":"6","key":"2294_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186889","volume":"135","author":"MA Liegeois","year":"2025","unstructured":"Liegeois MA, Hsieh A, Al-Fouadi M, et al. Cellular and molecular features of asthma mucus plugs provide clues about their formation and persistence. J Clin Investig. 2025;135(6):e186889. https:\/\/doi.org\/10.1172\/JCI186889.","journal-title":"J Clin Investig"},{"issue":"1","key":"2294_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.alit.2025.07.003","volume":"75","author":"N Tanabe","year":"2026","unstructured":"Tanabe N, Matsumoto H. From mucus plugging to airway dilatation in chronic airway diseases: a perspective on the contribution of the airway microbiome and inflammation. Allergol Int. 2026;75(1):32\u201341. https:\/\/doi.org\/10.1016\/j.alit.2025.07.003.","journal-title":"Allergol Int"},{"issue":"4","key":"2294_CR23","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","volume":"102","author":"DB Hill","year":"2022","unstructured":"Hill DB, Button B, Rubinstein M, Boucher RC. Physiology and pathophysiology of human airway mucus. Physiol Rev. 2022;102(4):1757\u2013836. https:\/\/doi.org\/10.1152\/physrev.00004.2021.","journal-title":"Physiol Rev"},{"issue":"3","key":"2294_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031933","volume":"25","author":"M Abrami","year":"2024","unstructured":"Abrami M, Biasin A, Tescione F, et al. Mucus structure, viscoelastic properties, and composition in chronic respiratory diseases. Int J Mol Sci. 2024;25(3):1933. https:\/\/doi.org\/10.3390\/ijms25031933.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2294_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1164\/rccm.202406-1244ED","volume":"210","author":"WW Busse","year":"2024","unstructured":"Busse WW, Jarjour NN. Breaking up mucus plugs in asthma. Am J Respir Crit Care Med. 2024;210(12):1389\u201390. https:\/\/doi.org\/10.1164\/rccm.202406-1244ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2294_CR26","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.cell.2021.04.019","volume":"184","author":"H Hammad","year":"2021","unstructured":"Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(9):2521\u20132. https:\/\/doi.org\/10.1016\/j.cell.2021.04.019.","journal-title":"Cell"},{"issue":"10379","key":"2294_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","volume":"401","author":"C Porsbjerg","year":"2023","unstructured":"Porsbjerg C, Mel\u00e9n E, Lehtim\u00e4ki L, Shaw D. Asthma. Lancet. 2023;401(10379):858\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(22)02125-0.","journal-title":"Lancet"},{"issue":"6","key":"2294_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.chest.2019.02.403","volume":"155","author":"S Svenningsen","year":"2019","unstructured":"Svenningsen S, Haider E, Boylan C, et al. CT and functional MRI to evaluate airway mucus in severe asthma. Chest. 2019;155(6):1178\u201389. https:\/\/doi.org\/10.1016\/j.chest.2019.02.403.","journal-title":"Chest"},{"issue":"9435","key":"2294_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","volume":"364","author":"JC Hogg","year":"2004","unstructured":"Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(04)16900-6.","journal-title":"Lancet"},{"issue":"3","key":"2294_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1378\/chest.10-2948","volume":"140","author":"V Kim","year":"2011","unstructured":"Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3):626\u201333. https:\/\/doi.org\/10.1378\/chest.10-2948.","journal-title":"Chest"},{"issue":"6","key":"2294_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMra2202819","volume":"387","author":"AE O'Donnell","year":"2022","unstructured":"O\u2019Donnell AE. Bronchiectasis\u2014a clinical review. N Engl J Med. 2022;387(6):533\u201345. https:\/\/doi.org\/10.1056\/NEJMra2202819.","journal-title":"N Engl J Med"},{"issue":"176","key":"2294_CR32","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0179-2024","volume":"34","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Metersky M, Aliberti S, et al. Neutrophilic inflammation in bronchiectasis. Eur Respir Rev. 2025;34(176):240179. https:\/\/doi.org\/10.1183\/16000617.0179-2024.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"2294_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/jama.2025.2680","volume":"334","author":"AF Barker","year":"2025","unstructured":"Barker AF, Karamooz E. Non-cystic fibrosis bronchiectasis in adults: a review. JAMA. 2025;334(3):253\u201364. https:\/\/doi.org\/10.1001\/jama.2025.2680.","journal-title":"JAMA"},{"issue":"18","key":"2294_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMra2216474","volume":"389","author":"H Grasemann","year":"2023","unstructured":"Grasemann H, Ratjen F. Cystic fibrosis. N Engl J Med. 2023;389(18):1693\u2013707. https:\/\/doi.org\/10.1056\/NEJMra2216474.","journal-title":"N Engl J Med"},{"issue":"5","key":"2294_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nm1028","volume":"10","author":"M Mall","year":"2004","unstructured":"Mall M, Grubb BR, Harkema JR, O\u2019Neal WK, Boucher RC. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med. 2004;10(5):487\u201393. https:\/\/doi.org\/10.1038\/nm1028.","journal-title":"Nat Med"},{"issue":"Suppl 3","key":"2294_CR36","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1002\/ppul.24530","volume":"54","author":"CB Morrison","year":"2019","unstructured":"Morrison CB, Markovetz MR, Ehre C. Mucus, mucins, and cystic fibrosis. Pediatr Pulmonol. 2019;54(Suppl 3):S84\u201396. https:\/\/doi.org\/10.1002\/ppul.24530.","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"2294_CR37","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01297-2018","volume":"52","author":"DB Hill","year":"2018","unstructured":"Hill DB, Long RF, Kissner WJ, et al. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH. Eur Respir J. 2018;52(6):1801297. https:\/\/doi.org\/10.1183\/13993003.01297-2018.","journal-title":"Eur Respir J"},{"issue":"4","key":"2294_CR38","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1021\/acsnano.4c14927","volume":"19","author":"O Ponomarchuk","year":"2025","unstructured":"Ponomarchuk O, Boudreault F, Gryczynski I, et al. Nanoscale viscometry reveals an inherent mucus defect in cystic fibrosis. ACS Nano. 2025;19(4):4637\u201349. https:\/\/doi.org\/10.1021\/acsnano.4c14927.","journal-title":"ACS Nano"},{"issue":"2","key":"2294_CR39","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4049\/jimmunol.175.2.1090","volume":"175","author":"H Matsui","year":"2005","unstructured":"Matsui H, Verghese MW, Kesimer M, et al. Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J Immunol. 2005;175(2):1090\u20139. https:\/\/doi.org\/10.4049\/jimmunol.175.2.1090.","journal-title":"J Immunol"},{"issue":"9621","key":"2294_CR40","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S0140-6736(08)60595-4","volume":"371","author":"KF Chung","year":"2008","unstructured":"Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008;371(9621):1364\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(08)60595-4.","journal-title":"Lancet"},{"issue":"3","key":"2294_CR41","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1378\/chest.14-2506","volume":"147","author":"LP Boulet","year":"2015","unstructured":"Boulet LP, Coeytaux RR, McCrory DC, et al. Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest. 2015;147(3):804\u201314. https:\/\/doi.org\/10.1378\/chest.14-2506.","journal-title":"Chest"},{"key":"2294_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.106921","volume":"200","author":"R Hughes","year":"2022","unstructured":"Hughes R, Rapsomaniki E, Janson C, et al. Frequent productive cough: symptom burden and future exacerbation risk among patients with asthma and\/or COPD in the NOVELTY study. Respir Med. 2022;200:106921. https:\/\/doi.org\/10.1016\/j.rmed.2022.106921.","journal-title":"Respir Med"},{"issue":"5","key":"2294_CR43","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/rccm.202403-0632OC","volume":"211","author":"E Wan","year":"2025","unstructured":"Wan E, Yen A, Elalami R, et al. Airway mucus plugs on chest computed tomography are associated with exacerbations in COPD. Am J Respir Crit Care Med. 2025;211(5):814\u201322. https:\/\/doi.org\/10.1164\/rccm.202403-0632OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2294_CR44","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.chest.2023.11.033","volume":"166","author":"SK Mettler","year":"2024","unstructured":"Mettler SK, Nath HP, Grumley S, et al. Silent airway mucus plugs in COPD and clinical implications. Chest. 2024;166(5):1010\u20139. https:\/\/doi.org\/10.1016\/j.chest.2023.11.033.","journal-title":"Chest"},{"issue":"3","key":"2294_CR45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.chest.2025.03.026","volume":"168","author":"X Li","year":"2025","unstructured":"Li X, Feng S, Yang Y, et al. Association between airway mucus plugs and risk of moderate-to-severe exacerbations in patients with COPD: results from a Chinese prospective cohort study. Chest. 2025;168(3):627\u201338. https:\/\/doi.org\/10.1016\/j.chest.2025.03.026.","journal-title":"Chest"},{"key":"2294_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.106982","volume":"202","author":"C Tran","year":"2022","unstructured":"Tran C, Singh GV, Haider E, et al. Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: a single-centered, retrospective, observational study. Respir Med. 2022;202:106982. https:\/\/doi.org\/10.1016\/j.rmed.2022.106982.","journal-title":"Respir Med"},{"issue":"5","key":"2294_CR47","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaip.2025.01.010","volume":"13","author":"J G\u00f6tschke","year":"2025","unstructured":"G\u00f6tschke J, Walter J, Leuschner G, et al. Mucus plug score predicts clinical and pulmonary function response to biologic therapy in patients with severe asthma. J Allergy Clin Immunol Pract. 2025;13(5):1110-1122.e1. https:\/\/doi.org\/10.1016\/j.jaip.2025.01.010.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2294_CR48","doi-asserted-by":"publisher","first-page":"2101499","DOI":"10.1183\/13993003.01499-2021","volume":"60","author":"S Stanojevic","year":"2022","unstructured":"Stanojevic S, Kaminsky DA, Miller MR, et al. ERS\/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499. https:\/\/doi.org\/10.1183\/13993003.01499-2021.","journal-title":"Eur Respir J"},{"key":"2294_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/5584_2016_208","volume":"980","author":"T Piorunek","year":"2017","unstructured":"Piorunek T, Kostrzewska M, Stelmach-Mardas M, et al. Small airway obstruction in chronic obstructive pulmonary disease: potential parameters for early detection. Adv Exp Med Biol. 2017;980:75\u201382. https:\/\/doi.org\/10.1007\/5584_2016_208.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2294_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4187\/respcare.01411","volume":"57","author":"DA Kaminsky","year":"2012","unstructured":"Kaminsky DA. What does airway resistance tell us about lung function? Respir Care. 2012;57(1):85\u201399. https:\/\/doi.org\/10.4187\/respcare.01411.","journal-title":"Respir Care"},{"issue":"1","key":"2294_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01662-7","volume":"22","author":"LY Li","year":"2021","unstructured":"Li LY, Yan TS, Yang J, et al. Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function. Respir Res. 2021;22(1):68. https:\/\/doi.org\/10.1186\/s12931-021-01662-7.","journal-title":"Respir Res"},{"issue":"2","key":"2294_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292270","volume":"19","author":"R Kraemer","year":"2024","unstructured":"Kraemer R, Baty F, Smith HJ, et al. Assessment of functional diversities in patients with asthma, COPD, asthma-COPD overlap, and Cystic Fibrosis (CF). PLoS ONE. 2024;19(2):e0292270. https:\/\/doi.org\/10.1371\/journal.pone.0292270.","journal-title":"PLoS ONE"},{"issue":"11","key":"2294_CR53","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S2213-2600(21)00079-5","volume":"9","author":"G Radicioni","year":"2021","unstructured":"Radicioni G, Ceppe A, Ford AA, et al. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2021;9(11):1241\u201354. https:\/\/doi.org\/10.1016\/S2213-2600(21)00079-5.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2294_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.alit.2021.09.003","volume":"71","author":"T Tajiri","year":"2022","unstructured":"Tajiri T, Matsumoto H, Jinnai M, et al. Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. Allergol Int. 2022;71(2):193\u20139. https:\/\/doi.org\/10.1016\/j.alit.2021.09.003.","journal-title":"Allergol Int"},{"issue":"24","key":"2294_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413653","volume":"25","author":"T Pincikova","year":"2024","unstructured":"Pincikova T, Merikallio H, Kotortsi I, et al. Expression levels of MUC5AC and MUC5B in airway goblet cells are associated with traits of COPD and progression of chronic airflow limitation. Int J Mol Sci. 2024;25(24):13653. https:\/\/doi.org\/10.3390\/ijms252413653.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2294_CR56","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.chest.2025.07.4087","volume":"168","author":"E Cant","year":"2025","unstructured":"Cant E, Bottier M, Shuttleworth M, et al. Inflammatory and mucociliary dysfunction-based endotypes across the spectrum of chronic airway diseases. Chest. 2025;168(6):1317\u201329. https:\/\/doi.org\/10.1016\/j.chest.2025.07.4087.","journal-title":"Chest"},{"issue":"4","key":"2294_CR57","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcf.2021.10.009","volume":"21","author":"A Lepissier","year":"2022","unstructured":"Lepissier A, Addy C, Hayes K, et al. Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge. J Cyst Fibros. 2022;21(4):691\u2013706. https:\/\/doi.org\/10.1016\/j.jcf.2021.10.009.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"2294_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/17576180.2025.2457844","volume":"17","author":"W Sun","year":"2025","unstructured":"Sun W, Mou S, Huntington C, et al. Development and qualification of an LC-MS\/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum. Bioanalysis. 2025;17(3):187\u201398. https:\/\/doi.org\/10.1080\/17576180.2025.2457844.","journal-title":"Bioanalysis"},{"issue":"5","key":"2294_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001287.pub6","volume":"5","author":"P Poole","year":"2019","unstructured":"Poole P, Sathananthan K, Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019;5(5):CD001287. https:\/\/doi.org\/10.1002\/14651858.CD001287.pub6.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2294_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1078-y","volume":"20","author":"P Rogliani","year":"2019","unstructured":"Rogliani P, Matera MG, Page C, Puxeddu E, Cazzola M, Calzetta L. Efficacy and safety profile of mucolytic\/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respir Res. 2019;20(1):104. https:\/\/doi.org\/10.1186\/s12931-019-1078-y.","journal-title":"Respir Res"},{"issue":"1","key":"2294_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02500-8","volume":"24","author":"M Cazzola","year":"2023","unstructured":"Cazzola M, Page CP, Wedzicha JA, Celli BR, Anzueto A, Matera MG. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD. Respir Res. 2023;24(1):194. https:\/\/doi.org\/10.1186\/s12931-023-02500-8.","journal-title":"Respir Res"},{"issue":"9470","key":"2294_CR62","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","volume":"365","author":"M Decramer","year":"2005","unstructured":"Decramer M, Rutten-van M\u00f6lken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005;365(9470):1552\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(05)66456-2.","journal-title":"Lancet"},{"issue":"9629","key":"2294_CR63","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","volume":"371","author":"JP Zheng","year":"2008","unstructured":"Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet. 2008;371(9629):2013\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(08)60869-7.","journal-title":"Lancet"},{"issue":"3","key":"2294_CR64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02265-2016","volume":"50","author":"JA Wedzicha","year":"2017","unstructured":"Wedzicha JA, Calverley PMA, Albert RK, et al. Prevention of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline. Eur Respir J. 2017;50(3):1602265. https:\/\/doi.org\/10.1183\/13993003.02265-2016.","journal-title":"Eur Respir J"},{"issue":"1","key":"2294_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51079-1","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wu F, Shi Z, et al. Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial. Nat Commun. 2024;15(1):8468. https:\/\/doi.org\/10.1038\/s41467-024-51079-1.","journal-title":"Nat Commun"},{"issue":"16","key":"2294_CR66","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","volume":"393","author":"JM Bradley","year":"2025","unstructured":"Bradley JM, O\u2019Neill B, McAuley DF, et al. Hypertonic saline or carbocisteine in bronchiectasis. N Engl J Med. 2025;393(16):1565\u201377. https:\/\/doi.org\/10.1056\/NEJMoa2510095.","journal-title":"N Engl J Med"},{"issue":"1","key":"2294_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1042-x","volume":"20","author":"Q Qi","year":"2019","unstructured":"Qi Q, Ailiyaer Y, Liu R, et al. Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial. Respir Res. 2019;20(1):73. https:\/\/doi.org\/10.1186\/s12931-019-1042-x.","journal-title":"Respir Res"},{"key":"2294_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2023.102283","volume":"84","author":"L Jayaram","year":"2024","unstructured":"Jayaram L, King PT, Hunt J, et al. Evaluation of high dose N- acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: a randomised placebo-controlled pilot study. Pulm Pharmacol Ther. 2024;84:102283. https:\/\/doi.org\/10.1016\/j.pupt.2023.102283.","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"2294_CR69","doi-asserted-by":"publisher","first-page":"2501126","DOI":"10.1183\/13993003.01126-2025","volume":"66","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Haworth CS, Flume P, et al. European Respiratory Society clinical practice guideline for the management of adult bronchiectasis. Eur Respir J. 2025;66(6):2501126. https:\/\/doi.org\/10.1183\/13993003.01126-2025.","journal-title":"Eur Respir J"},{"issue":"2","key":"2294_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/phrs.2001.0917","volume":"45","author":"S Blesa","year":"2002","unstructured":"Blesa S, Cortijo J, Martinez-Losa M, et al. Effectiveness of oral N -acetylcysteine in a rat experimental model of asthma. Pharmacol Res. 2002;45(2):135\u201340. https:\/\/doi.org\/10.1006\/phrs.2001.0917.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2294_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20499-0","volume":"12","author":"LE Morgan","year":"2021","unstructured":"Morgan LE, Jaramillo AM, Shenoy SK, et al. Disulfide disruption reverses mucus dysfunction in allergic airway disease. Nat Commun. 2021;12(1):249. https:\/\/doi.org\/10.1038\/s41467-020-20499-0.","journal-title":"Nat Commun"},{"issue":"7","key":"2294_CR72","doi-asserted-by":"publisher","first-page":"11161","DOI":"10.1021\/acsnano.2c03993","volume":"16","author":"D Zhao","year":"2022","unstructured":"Zhao D, Li D, Cheng X, Zou Z, Chen X, He C. Mucoadhesive, antibacterial, and reductive nanogels as a mucolytic agent for efficient nebulized therapy to combat allergic asthma. ACS Nano. 2022;16(7):11161\u201373. https:\/\/doi.org\/10.1021\/acsnano.2c03993.","journal-title":"ACS Nano"},{"issue":"7","key":"2294_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007168.pub3","volume":"2013","author":"J Tam","year":"2013","unstructured":"Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. Cochrane Database Syst Rev. 2013;2013(7):CD007168. https:\/\/doi.org\/10.1002\/14651858.CD007168.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2294_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007020.pub4","volume":"10","author":"O Ciofu","year":"2019","unstructured":"Ciofu O, Smith S, Lykkesfeldt J. Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2019;10(10):CD007020. https:\/\/doi.org\/10.1002\/14651858.CD007020.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2294_CR75","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.chest.2021.04.039","volume":"160","author":"L McGarvey","year":"2021","unstructured":"McGarvey L, Rubin BK, Ebihara S, et al. Global physiology and pathophysiology of cough: part 2. Demographic and clinical considerations: CHEST expert panel report. Chest. 2021;160(4):1413\u201323. https:\/\/doi.org\/10.1016\/j.chest.2021.04.039.","journal-title":"Chest"},{"issue":"6","key":"2294_CR76","doi-asserted-by":"publisher","first-page":"S291","DOI":"10.1067\/mai.2002.129704","volume":"110","author":"WD Bennett","year":"2002","unstructured":"Bennett WD. Effect of beta-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol. 2002;110(6):S291\u20137. https:\/\/doi.org\/10.1067\/mai.2002.129704.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2294_CR77","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.rmed.2011.02.007","volume":"105","author":"T Meyer","year":"2011","unstructured":"Meyer T, Reitmeir P, Brand P, et al. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. Respir Med. 2011;105(6):900\u20136. https:\/\/doi.org\/10.1016\/j.rmed.2011.02.007.","journal-title":"Respir Med"},{"key":"2294_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pupt.2016.06.008","volume":"39","author":"E Tagaya","year":"2016","unstructured":"Tagaya E, Yagi O, Sato A, et al. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD. Pulm Pharmacol Ther. 2016;39:81\u20134. https:\/\/doi.org\/10.1016\/j.pupt.2016.06.008.","journal-title":"Pulm Pharmacol Ther"},{"issue":"164","key":"2294_CR79","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0196-2021","volume":"31","author":"L Calzetta","year":"2022","unstructured":"Calzetta L, Ritondo BL, Zappa MC, et al. The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. Eur Respir Rev. 2022;31(164):210196. https:\/\/doi.org\/10.1183\/16000617.0196-2021.","journal-title":"Eur Respir Rev"},{"key":"2294_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1341644","volume":"2021","author":"S Yu","year":"2021","unstructured":"Yu S, Zhang C, Yan Z, Fang Q, Gao X. Tiotropium bromide attenuates mucus hypersecretion in patients with stable chronic obstructive pulmonary disease. Comput Math Methods Med. 2021;2021:1341644. https:\/\/doi.org\/10.1155\/2021\/1341644.","journal-title":"Comput Math Methods Med"},{"issue":"9","key":"2294_CR81","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4187\/respcare.07521159","volume":"52","author":"RD Restrepo","year":"2007","unstructured":"Restrepo RD. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance? Respir Care. 2007;52(9):1159\u201375.","journal-title":"Respir Care"},{"issue":"2","key":"2294_CR82","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/thx.52.2.176","volume":"52","author":"M Moretti","year":"1997","unstructured":"Moretti M, Lopez-Vidriero MT, Pavia D, Clarke SW. Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis. Thorax. 1997;52(2):176\u201380. https:\/\/doi.org\/10.1136\/thx.52.2.176.","journal-title":"Thorax"},{"issue":"9","key":"2294_CR83","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/MLG.0b013e31817b0732","volume":"118","author":"HP Hauber","year":"2008","unstructured":"Hauber HP, Steffen A, Goldmann T, et al. Effect of steroids, acetyl-cysteine and calcium-activated chloride channel inhibitors on allergic mucin expression in sinus mucosa. Laryngoscope. 2008;118(9):1528\u201333. https:\/\/doi.org\/10.1097\/MLG.0b013e31817b0732.","journal-title":"Laryngoscope"},{"issue":"10","key":"2294_CR84","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/j.1398-9995.2008.01678.x","volume":"63","author":"A Mart\u00ednez-Ant\u00f3n","year":"2008","unstructured":"Mart\u00ednez-Ant\u00f3n A, de Bol\u00f3s C, Alobid I, et al. Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps. Allergy. 2008;63(10):1368\u201376. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01678.x.","journal-title":"Allergy"},{"issue":"12","key":"2294_CR85","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/cea.13015","volume":"47","author":"ME Lachowicz-Scroggins","year":"2017","unstructured":"Lachowicz-Scroggins ME, Finkbeiner WE, Gordon ED, et al. Corticosteroid and long\u2010acting \u03b2\u2010agonist therapy reduces epithelial goblet cell metaplasia. Clin Exp Allergy. 2017;47(12):1534\u201345. https:\/\/doi.org\/10.1111\/cea.13015.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"2294_CR86","doi-asserted-by":"publisher","first-page":"C225","DOI":"10.1152\/ajpcell.00073.2016","volume":"311","author":"NA Zaidman","year":"2016","unstructured":"Zaidman NA, Panoskaltsis-Mortari A, O\u2019Grady SM. Differentiation of human bronchial epithelial cells: role of hydrocortisone in development of ion transport pathways involved in mucociliary clearance. Am J Physiol Cell Physiol. 2016;311(2):C225\u201336. https:\/\/doi.org\/10.1152\/ajpcell.00073.2016.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"2294_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04574-1","volume":"9","author":"A Singanayagam","year":"2018","unstructured":"Singanayagam A, Glanville N, Girkin JL, et al. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations. Nat Commun. 2018;9(1):2229. https:\/\/doi.org\/10.1038\/s41467-018-04574-1.","journal-title":"Nat Commun"},{"issue":"3","key":"2294_CR88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.alit.2024.03.001","volume":"73","author":"C Venegas Garrido","year":"2024","unstructured":"Venegas Garrido C, Mukherjee M, Svenningsen S, Nair P. Eosinophil-mucus interplay in severe asthma: implications for treatment with biologicals. Allergol Int. 2024;73(3):351\u201361. https:\/\/doi.org\/10.1016\/j.alit.2024.03.001.","journal-title":"Allergol Int"},{"issue":"12","key":"2294_CR89","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1172\/JCI64896","volume":"122","author":"YG Alevy","year":"2012","unstructured":"Alevy YG, Patel AC, Romero AG, et al. IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. J Clin Investig. 2012;122(12):4555\u201368. https:\/\/doi.org\/10.1172\/JCI64896.","journal-title":"J Clin Investig"},{"issue":"3","key":"2294_CR90","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","volume":"73","author":"T Tajiri","year":"2024","unstructured":"Tajiri T, Suzuki M, Nishiyama H, et al. Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A\u00a0prospective, observational study. Allergol Int. 2024;73(3):406\u201315. https:\/\/doi.org\/10.1016\/j.alit.2024.02.002.","journal-title":"Allergol Int"},{"key":"2294_CR91","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202410-1894OC","author":"C Porsbjerg","year":"2025","unstructured":"Porsbjerg C, Dunican EM, Lugogo NL, et al. Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial. Am J Respir Crit Care Med. 2025. https:\/\/doi.org\/10.1164\/rccm.202410-1894OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2294_CR92","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1159\/000530392","volume":"184","author":"N Sakai","year":"2023","unstructured":"Sakai N, Koya T, Murai Y, et al. Effect of benralizumab on mucus plugs in severe eosinophilic asthma. Int Arch Allergy Immunol. 2023;184(8):783\u201391. https:\/\/doi.org\/10.1159\/000530392.","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"2294_CR93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.chest.2023.02.009","volume":"164","author":"MJ McIntosh","year":"2023","unstructured":"McIntosh MJ, Kooner HK, Eddy RL, et al. CT mucus score and 129Xe MRI ventilation defects after 2.5 years\u2019 anti-IL-5R\u03b1 in eosinophilic asthma. Chest. 2023;164(1):27\u201338. https:\/\/doi.org\/10.1016\/j.chest.2023.02.009.","journal-title":"Chest"},{"issue":"5","key":"2294_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052287","volume":"26","author":"A Asbjarnarson","year":"2025","unstructured":"Asbjarnarson A, Joelsson JP, Gardarsson FR, et al. The non-antibacterial effects of azithromycin and other macrolides on the bronchial epithelial barrier and cellular differentiation. Int J Mol Sci. 2025;26(5):2287. https:\/\/doi.org\/10.3390\/ijms26052287.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2294_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121257","volume":"10","author":"W Ni","year":"2015","unstructured":"Ni W, Shao X, Cai X, et al. Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis. PLoS ONE. 2015;10(3):e0121257. https:\/\/doi.org\/10.1371\/journal.pone.0121257.","journal-title":"PLoS ONE"},{"issue":"10408","key":"2294_CR96","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","volume":"402","author":"JL Taylor-Cousar","year":"2023","unstructured":"Taylor-Cousar JL, Robinson PD, Shteinberg M, Downey DG. CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis. Lancet. 2023;402(10408):1171\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(23)01609-4.","journal-title":"Lancet"},{"issue":"1","key":"2294_CR97","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcf.2023.10.010","volume":"23","author":"SH Donaldson","year":"2024","unstructured":"Donaldson SH, Corcoran TE, Pilewski JM, et al. Effect of elexacaftor\/tezacaftor\/ivacaftor on mucus and mucociliary clearance in cystic fibrosis. J Cyst Fibros. 2024;23(1):155\u201360. https:\/\/doi.org\/10.1016\/j.jcf.2023.10.010.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"2294_CR98","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/s-0042-1758851","volume":"44","author":"L Regard","year":"2023","unstructured":"Regard L, Martin C, Da Silva J, Burgel PR. CFTR modulators: current status and evolving knowledge. Semin Respir Crit Care Med. 2023;44(2):186\u201395. https:\/\/doi.org\/10.1055\/s-0042-1758851.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"2294_CR99","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1021\/acs.jmedchem.4c02547","volume":"68","author":"X Wang","year":"2025","unstructured":"Wang X, Tse C, Singh A. Discovery and development of CFTR modulators for the treatment of cystic fibrosis. J Med Chem. 2025;68(3):2255\u2013300. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02547.","journal-title":"J Med Chem"},{"issue":"5","key":"2294_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008649.pub4","volume":"5","author":"SJ Nevitt","year":"2020","unstructured":"Nevitt SJ, Thornton J, Murray CS, Dwyer T. Inhaled mannitol for cystic fibrosis. Cochrane Database Syst Rev. 2020;5(5):CD008649. https:\/\/doi.org\/10.1002\/14651858.CD008649.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2294_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002996.pub3","volume":"2014","author":"A Hart","year":"2014","unstructured":"Hart A, Sugumar K, Milan SJ, Fowler SJ, Crossingham I. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev. 2014;2014(5):CD002996. https:\/\/doi.org\/10.1002\/14651858.CD002996.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2294_CR102","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2022","volume":"62","author":"B Herrero-Cortina","year":"2023","unstructured":"Herrero-Cortina B, Lee AL, Oliveira A, et al. European respiratory society statement on airway clearance techniques in adults with bronchiectasis. Eur Respir J. 2023;62(1):2202053. https:\/\/doi.org\/10.1183\/13993003.02053-2022.","journal-title":"Eur Respir J"},{"issue":"1 Suppl","key":"2294_CR103","doi-asserted-by":"publisher","first-page":"250S","DOI":"10.1378\/chest.129.1_suppl.250S","volume":"129","author":"FD McCool","year":"2006","unstructured":"McCool FD, Rosen MJ. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):250S-259S. https:\/\/doi.org\/10.1378\/chest.129.1_suppl.250S.","journal-title":"Chest"},{"issue":"11","key":"2294_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008351.pub3","volume":"2015","author":"AL Lee","year":"2015","unstructured":"Lee AL, Burge AT, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev. 2015;2015(11):CD008351. https:\/\/doi.org\/10.1002\/14651858.CD008351.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2294_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006842.pub5","volume":"4","author":"L Morrison","year":"2020","unstructured":"Morrison L, Milroy S. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev. 2020;4(4):CD006842. https:\/\/doi.org\/10.1002\/14651858.CD006842.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2294_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007862.pub5","volume":"2","author":"LM Wilson","year":"2023","unstructured":"Wilson LM, Saldanha IJ, Robinson KA. Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst Rev. 2023;2(2):CD007862. https:\/\/doi.org\/10.1002\/14651858.CD007862.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2294_CR107","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/resp.13459","volume":"24","author":"K O'Neill","year":"2019","unstructured":"O\u2019Neill K, O\u2019Donnell AE, Bradley JM. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis. Respirology. 2019;24(3):227\u201337. https:\/\/doi.org\/10.1111\/resp.13459.","journal-title":"Respirology"},{"issue":"5","key":"2294_CR108","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02022-2022","volume":"61","author":"A Addante","year":"2023","unstructured":"Addante A, Raymond W, Gitlin I, et al. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases. Eur Respir J. 2023;61(5):2202022. https:\/\/doi.org\/10.1183\/13993003.02022-2022.","journal-title":"Eur Respir J"},{"key":"2294_CR109","doi-asserted-by":"publisher","first-page":"A4050","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A4050","volume":"211","author":"J Low","year":"2025","unstructured":"Low J, Fuller RW, Gitlin I, et al. Safety and tolerability of a novel inhaled thiol-saccharide mucolytic (fexlamose, MUC-031) in healthy volunteers [abstract]. Am J Respir Crit Care Med. 2025;211:A4050. https:\/\/doi.org\/10.1164\/ajrccm.2025.211.Abstracts.A4050.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2294_CR110","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1164\/rccm.201802-0245OC","volume":"199","author":"C Ehre","year":"2019","unstructured":"Ehre C, Rushton ZL, Wang B, et al. An improved inhaled mucolytic to treat airway muco-obstructive diseases. Am J Respir Crit Care Med. 2019;199(2):171\u201380. https:\/\/doi.org\/10.1164\/rccm.201802-0245OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"2294_CR111","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1039\/d4bm00381k","volume":"12","author":"J Arenhoevel","year":"2024","unstructured":"Arenhoevel J, Kuppe A, Addante A, et al. Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases. Biomater Sci. 2024;12(17):4376\u201385. https:\/\/doi.org\/10.1039\/d4bm00381k.","journal-title":"Biomater Sci"},{"issue":"2","key":"2294_CR112","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jcf.2020.11.002","volume":"20","author":"S Kazani","year":"2021","unstructured":"Kazani S, Rowlands DJ, Bottoli I, et al. Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251). J Cyst Fibros. 2021;20(2):250\u20136. https:\/\/doi.org\/10.1016\/j.jcf.2020.11.002.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"2294_CR113","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.202303-0458OC","volume":"208","author":"FJ Martinez","year":"2023","unstructured":"Martinez FJ, Criner GJ, Gessner C, et al. Icenticaftor, a CFTR potentiator, in COPD: a multicenter, parallel-group, double-blind clinical trial. Am J Respir Crit Care Med. 2023;208(4):417\u201327. https:\/\/doi.org\/10.1164\/rccm.202303-0458OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2294_CR114","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/1440-1681.12744","volume":"44","author":"A Ermund","year":"2017","unstructured":"Ermund A, Recktenwald CV, Skj\u00e5k-Braek G, et al. OligoG CF-5\/20 normalizes cystic fibrosis mucus by chelating calcium. Clin Exp Pharmacol Physiol. 2017;44(6):639\u201347. https:\/\/doi.org\/10.1111\/1440-1681.12744.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"2294_CR115","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1021\/acs.molpharmaceut.5b00794","volume":"13","author":"MF Pritchard","year":"2016","unstructured":"Pritchard MF, Powell LC, Menzies GE, et al. A new class of safe oligosaccharide polymer therapy to modify the mucus barrier of chronic respiratory disease. Mol Pharm. 2016;13(3):863\u201372. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00794.","journal-title":"Mol Pharm"},{"issue":"1","key":"2294_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08927-1","volume":"12","author":"J Stokniene","year":"2022","unstructured":"Stokniene J, Varache M, Rye PD, Hill KE, Thomas DW, Ferguson EL. Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment. Sci Rep. 2022;12(1):4986. https:\/\/doi.org\/10.1038\/s41598-022-08927-1.","journal-title":"Sci Rep"},{"issue":"1","key":"2294_CR117","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MCP.0000000000001036","volume":"30","author":"A Tana","year":"2024","unstructured":"Tana A, Zhang C, DiBardino D, Orton CM, Shah PL. Bronchoscopic interventions for chronic bronchitis. Curr Opin Pulm Med. 2024;30(1):68\u201374. https:\/\/doi.org\/10.1097\/MCP.0000000000001036.","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"2294_CR118","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.chest.2023.02.044","volume":"164","author":"M Kirby","year":"2023","unstructured":"Kirby M, Smith BM. Quantitative CT scan imaging of the airways for diagnosis and management of lung disease. Chest. 2023;164(5):1150\u20138. https:\/\/doi.org\/10.1016\/j.chest.2023.02.044.","journal-title":"Chest"},{"issue":"1","key":"2294_CR119","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chest.2019.12.046","volume":"158","author":"Y Okajima","year":"2020","unstructured":"Okajima Y, Come CE, Nardelli P, et al. Luminal plugging on chest CT scan: association with lung function, quality of life, and COPD clinical phenotypes. Chest. 2020;158(1):121\u201330. https:\/\/doi.org\/10.1016\/j.chest.2019.12.046.","journal-title":"Chest"},{"issue":"3","key":"2294_CR120","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00844-2021","volume":"59","author":"G Dournes","year":"2022","unstructured":"Dournes G, Hall CS, Willmering MM, et al. Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators. Eur Respir J. 2022;59(3):2100844. https:\/\/doi.org\/10.1183\/13993003.00844-2021.","journal-title":"Eur Respir J"},{"issue":"2","key":"2294_CR121","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/thorax-2024-221928","volume":"80","author":"T van der Veer","year":"2025","unstructured":"van der Veer T, Andrinopoulou ER, Braunstahl GJ, et al. Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD. Thorax. 2025;80(2):105\u20138. https:\/\/doi.org\/10.1136\/thorax-2024-221928.","journal-title":"Thorax"},{"issue":"2","key":"2294_CR122","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S2213-2600(19)30374-1","volume":"8","author":"JS Lucas","year":"2020","unstructured":"Lucas JS, Davis SD, Omran H, Shoemark A. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med. 2020;8(2):202\u201316. https:\/\/doi.org\/10.1016\/S2213-2600(19)30374-1.","journal-title":"Lancet Respir Med"},{"key":"2294_CR123","doi-asserted-by":"publisher","DOI":"10.1111\/all.70197","author":"R Poto","year":"2025","unstructured":"Poto R, Chan R, Pelaia C, Canonica GW, Virchow JC, Varricchi G. The role of biologics in reducing mucous plug burden in asthma. Allergy. 2025. https:\/\/doi.org\/10.1111\/all.70197.","journal-title":"Allergy"},{"issue":"5","key":"2294_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050812","volume":"11","author":"J Charriot","year":"2022","unstructured":"Charriot J, Volpato M, Petit A, Vachier I, Bourdin A. Methods of sputum and mucus assessment for muco-obstructive lung diseases in 2022: time to \u201cunplug\u201d from our daily routine! Cells. 2022;11(5):812. https:\/\/doi.org\/10.3390\/cells11050812.","journal-title":"Cells"},{"issue":"4","key":"2294_CR125","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.202108-1943OC","volume":"206","author":"JT Huang","year":"2022","unstructured":"Huang JT, Cant E, Keir HR, et al. Endotyping chronic obstructive pulmonary disease, bronchiectasis, and the \u201cchronic obstructive pulmonary disease-bronchiectasis association.\u201d Am J Respir Crit Care Med. 2022;206(4):417\u201326. https:\/\/doi.org\/10.1164\/rccm.202108-1943OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2294_CR126","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1164\/rccm.202303-0400SO","volume":"208","author":"M Cazzola","year":"2023","unstructured":"Cazzola M, Rogliani P, Barnes PJ, et al. An update on outcomes for COPD pharmacological trials: a COPD investigators report - reassessment of the 2008 American Thoracic Society\/European Respiratory Society statement on outcomes for COPD pharmacological trials. Am J Respir Crit Care Med. 2023;208(4):374\u201394. https:\/\/doi.org\/10.1164\/rccm.202303-0400SO.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2294_CR127","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1513\/AnnalsATS.202211-915ST","volume":"20","author":"CCW Hsia","year":"2023","unstructured":"Hsia CCW, Bates JHT, Driehuys B, et al. Quantitative imaging metrics for the assessment of pulmonary pathophysiology: an official American Thoracic Society and Fleischner Society joint workshop report. Ann Am Thorac Soc. 2023;20(2):161\u201395. https:\/\/doi.org\/10.1513\/AnnalsATS.202211-915ST.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"2294_CR128","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jcf.2025.08.003","volume":"24","author":"P Raut","year":"2025","unstructured":"Raut P, Chen Y, Taleb A, et al. Validation of an artificial intelligence-based automated PRAGMA and mucus plugging algorithm in pediatric cystic fibrosis. J Cyst Fibros. 2025;24(5):970\u20138. https:\/\/doi.org\/10.1016\/j.jcf.2025.08.003.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"2294_CR129","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MCP.0000000000001167","volume":"31","author":"S Fedosenko","year":"2025","unstructured":"Fedosenko S, Venegas Garrido C, Nair P. Recent advances in asthma mucus biology and emerging treatment strategies. Curr Opin Pulm Med. 2025;31(3):251\u201361. https:\/\/doi.org\/10.1097\/MCP.0000000000001167.","journal-title":"Curr Opin Pulm Med"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02294-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02294-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02294-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:00:54Z","timestamp":1774069254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-026-02294-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02294-1","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors have no conflicts of interest that are directly relevant to the content of this article. Mario Cazzola and Luigino Calzetta are Editorial Board members of\n                      Drugs\n                      . Mario Cazzola and Luigino Calzetta were not involved in the selection of peer reviewers for the manuscript, nor in any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the manuscript. Original draft preparation: Mario Cazzola. Writing, review, and editing: Paola Rogliani, Josuel Ora, Luigino Calzetta, and Maria Gabriella Matera. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}